Minoxidil Orifarm

Minoxidil, the active ingredient in Minoxidil Orifarm, is a potassium channel opener presented as a topical solution for cutaneous use. It is used to stimulate hair growth in androgenetic alopecia affecting both men and women. GNH USA supplies Minoxidil Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil Orifarm is a topical agent that acts on the hair‑growth cycle in pattern hair loss.

Androgenetic alopecia (male pattern): promotes regrowth of scalp hair and slows further loss. Androgenetic alopecia (female pattern): improves hair density and reduces thinning on the crown and frontal scalp. Alopecia areata (limited use): may aid in localized hair regrowth when applied under medical supervision.

Minoxidil Orifarm may cause local and systemic reactions.

Common Side Effects: - Scalp irritation: redness, itching, or burning sensation at the application site. - Dryness or flaking of the scalp skin. - Unwanted facial hair growth (hypertrichosis) near the treated area. - Temporary increase in hair shedding during the first weeks of use. - Contact dermatitis: rash or eczema from formulation components.

Serious or Rare Side Effects: - Rapid heart rate (tachycardia) or palpitations. - Dizziness or light‑headedness. - Swelling of hands, feet, or lower legs (edema). - Unexplained weight gain. - Severe allergic reaction: swelling of face, lips, or throat, difficulty breathing.

Before using Minoxidil Orifarm, consider the following safety measures.

Pregnancy and lactation: consult a healthcare professional before use; safety data are limited. Skin integrity: avoid application on irritated, infected, or damaged scalp skin. Age restrictions: not recommended for children under 18 years without medical advice. Concurrent hair treatments: discontinue use of other topical agents that may increase irritation. Allergy screening: check for sensitivity to any excipients in the formulation. Store at below 25°C: keep the container in its original packaging, protect from moisture and direct sunlight.

Minoxidil Orifarm can interact with systemic medications and other topical agents.

Major Interactions (Avoid): - Oral antihypertensives (e.g., beta‑blockers, ACE inhibitors): may potentiate blood‑pressure lowering effects. - Other vasodilators: additive hypotensive risk.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may increase skin absorption and systemic exposure. - Hair dyes or chemical treatments: could alter scalp condition and increase irritation. - Herbal supplements with vasodilatory properties (e.g., ginkgo, garlic): monitor blood pressure.